Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 16 studies | 40% ± 20% | |
astrocyte | 15 studies | 38% ± 16% | |
oligodendrocyte precursor cell | 15 studies | 54% ± 20% | |
oligodendrocyte | 14 studies | 34% ± 16% | |
adipocyte | 10 studies | 44% ± 14% | |
pericyte | 9 studies | 34% ± 13% | |
fibroblast | 7 studies | 29% ± 11% | |
smooth muscle cell | 6 studies | 31% ± 13% | |
GABAergic neuron | 5 studies | 30% ± 12% | |
glutamatergic neuron | 5 studies | 35% ± 13% | |
monocyte | 5 studies | 27% ± 6% | |
granule cell | 4 studies | 39% ± 20% | |
interneuron | 4 studies | 21% ± 4% | |
macrophage | 4 studies | 28% ± 15% | |
neuron | 4 studies | 31% ± 12% | |
microglial cell | 3 studies | 52% ± 17% | |
alveolar macrophage | 3 studies | 37% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 2398.00 | 1809 / 1809 | 100% | 68.98 | 470 / 472 |
brain | 100% | 1642.43 | 2636 / 2642 | 100% | 69.60 | 702 / 705 |
prostate | 99% | 2097.55 | 243 / 245 | 100% | 42.39 | 500 / 502 |
breast | 100% | 2558.68 | 459 / 459 | 99% | 75.45 | 1103 / 1118 |
ovary | 100% | 1786.63 | 180 / 180 | 90% | 16.06 | 389 / 430 |
adrenal gland | 97% | 776.64 | 251 / 258 | 75% | 10.65 | 172 / 230 |
esophagus | 93% | 744.09 | 1346 / 1445 | 78% | 15.58 | 142 / 183 |
uterus | 99% | 1568.31 | 169 / 170 | 58% | 11.63 | 268 / 459 |
lung | 92% | 720.62 | 532 / 578 | 57% | 9.84 | 653 / 1155 |
intestine | 83% | 559.82 | 801 / 966 | 63% | 10.01 | 334 / 527 |
thymus | 94% | 644.92 | 613 / 653 | 48% | 5.54 | 289 / 605 |
kidney | 65% | 454.80 | 58 / 89 | 73% | 12.37 | 661 / 901 |
pancreas | 73% | 359.50 | 241 / 328 | 62% | 8.45 | 110 / 178 |
stomach | 68% | 515.64 | 243 / 359 | 64% | 10.82 | 183 / 286 |
bladder | 76% | 573.14 | 16 / 21 | 43% | 6.86 | 219 / 504 |
adipose | 100% | 1998.45 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 46.09 | 80 / 80 |
blood vessel | 84% | 665.57 | 1118 / 1335 | 0% | 0 | 0 / 0 |
spleen | 71% | 343.61 | 171 / 241 | 0% | 0 | 0 / 0 |
muscle | 67% | 560.03 | 538 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 67% | 11.37 | 30 / 45 |
heart | 55% | 334.95 | 476 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 33% | 164.41 | 303 / 929 | 0% | 0 | 0 / 0 |
liver | 9% | 42.85 | 21 / 226 | 10% | 1.31 | 39 / 406 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.64 | 5 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070613 | Biological process | regulation of protein processing |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_0005886 | Cellular component | plasma membrane |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LDLRAD3 |
Protein name | Low density lipoprotein receptor class A domain containing 3 Low-density lipoprotein receptor class A domain-containing protein 3 (LDLR class A domain-containing protein 3) |
Synonyms | LRAD3 |
Description | FUNCTION: May influence APP processing, resulting in a decrease in sAPP-alpha production and increased amyloidogenic P3 peptide production. May regulate ITCH and NEDD4 E3 ligase activity and degradation . .; FUNCTION: (Microbial infection) Acts as a receptor for Venezuelan equine encephalitis virus. . |
Accessions | ENST00000528989.5 [Q86YD5-2] E9PR86 ENST00000315571.6 [Q86YD5-1] ENST00000524419.5 Q86YD5 |